학술논문

Effects of BI 655064, an antagonistic anti-CD40 antibody, on clinical and biomarker variables in patients with active rheumatoid arthritis: A randomised, double-blind, placebo-controlled, phase IIa study

Document Type

Article

Author

Visvanathan, S.; Ramanujam, M.; Vinisko, R.; Joseph, D.; Fine, J.S.; Daniluk, S.; Ptaszyński, R.; Müller-Ladner, U.; Rosenstock, B.; Eleftheraki, A.G.; Baum, P.; Steffgen, J.; Petříková, A.; Kellner, H.; Dokoupilova, E.; Kwiatkowska, B.; Alten, R.; Schwabe, C.; Padula, S.J.

Source

In: Annals of the Rheumatic Diseases. (Annals of the Rheumatic Diseases, 1 June 2019, 78(6):754-760)

Subject

Language

English

ISSN

14682060
00034967

Online Access

Full Text (BMJ Journals) Full Text (ProQuest Central) Web of Science JCR 저널정보 Scopus Find it@PNU

이메일

부산대학교 도서관

Online Access

메일 발송